Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP20-003, Network of Modeling Centers To Improve Evidence Base for Seasonal and Pandemic Influenza Prevention and Control; Amended Notice of Meeting, 1315 [2020-00255]

Download as PDF Federal Register / Vol. 85, No. 7 / Friday, January 10, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–IP20– 003, Network of Modeling Centers To Improve Evidence Base for Seasonal and Pandemic Influenza Prevention and Control; Amended Notice of Meeting Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP20–003, Network of Modeling Centers to Improve Evidence Base for Seasonal and Pandemic Influenza Prevention and Control; February 25–26, 2020, 10:00 a.m.–5:00 p.m., (EDT). Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta, GA 30329–4027 which was published in the Federal Register on November 25, 2019, Volume 84, Number 227, page 64897. The meeting is being amended to change the meeting date to February 25, 2020. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027; (404) 718– 8833; gca5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. jbell on DSKJLSW7X2PROD with NOTICES [FR Doc. 2020–00255 Filed 1–9–20; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP20–001, Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA). Date: March 11, 2020. Time: 10:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341; Telephone: (770) 488–6511; Email: kva5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P VerDate Sep<11>2014 16:39 Jan 09, 2020 [Docket No. CDC–2020–0002] [FR Doc. 2020–00256 Filed 1–9–20; 8:45 am] BILLING CODE 4163–18–P Jkt 250001 PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 1315 Advisory Committee on Immunization Practices (ACIP); Notice of Meeting and Request for Comment Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public, limited only by room seating. The meeting room accommodates 216 for public seating. Room 245, adjacent to the meeting room, will be available once the meeting room reaches capacity, providing up to 18 additional seats. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for meeting registration and more information on ACIP please visit the ACIP website: https://www.cdc.gov/ vaccines/acip/. DATES: The meeting will be held on February 26, 2020, 8:00 a.m. to 5:00 p.m., EST, and February 27, 2020, 8:00 a.m. to 2:30 p.m. EST. Written comments must be received on or before February 28, 2020. ADDRESSES: You may submit comments, identified by Docket No. CDC–2020– 0002 by any of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS A–27, Atlanta, GA 30329–4027, Attn: February ACIP Meeting. Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. Written public comments submitted by 72 hours prior to the ACIP meeting will be provided to ACIP members before the meeting. Meeting location: Centers for Disease Control and Prevention, 1600 Clifton SUMMARY: E:\FR\FM\10JAN1.SGM 10JAN1

Agencies

[Federal Register Volume 85, Number 7 (Friday, January 10, 2020)]
[Notices]
[Page 1315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00255]



[[Page 1315]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-IP20-003, Network of Modeling Centers To 
Improve Evidence Base for Seasonal and Pandemic Influenza Prevention 
and Control; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP20-003, Network of Modeling Centers to Improve Evidence 
Base for Seasonal and Pandemic Influenza Prevention and Control; 
February 25-26, 2020, 10:00 a.m.-5:00 p.m., (EDT).
    Teleconference, Centers for Disease Control and Prevention, Room 
1080, 8 Corporate Square Boulevard, Atlanta, GA 30329-4027 which was 
published in the Federal Register on November 25, 2019, Volume 84, 
Number 227, page 64897.
    The meeting is being amended to change the meeting date to February 
25, 2020. The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027; (404) 718-8833; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-00255 Filed 1-9-20; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.